Entry |
|
Symbol |
MAP2K1
|
Name |
(RefSeq) dual specificity mitogen-activated protein kinase kinase 1
|
KO |
|
Organism |
umr Ursus maritimus (polar bear)
|
Pathway |
umr01521 | EGFR tyrosine kinase inhibitor resistance |
umr04072 | Phospholipase D signaling pathway |
umr04270 | Vascular smooth muscle contraction |
umr04550 | Signaling pathways regulating pluripotency of stem cells |
umr04613 | Neutrophil extracellular trap formation |
umr04620 | Toll-like receptor signaling pathway |
umr04650 | Natural killer cell mediated cytotoxicity |
umr04660 | T cell receptor signaling pathway |
umr04662 | B cell receptor signaling pathway |
umr04664 | Fc epsilon RI signaling pathway |
umr04666 | Fc gamma R-mediated phagocytosis |
umr04810 | Regulation of actin cytoskeleton |
umr04914 | Progesterone-mediated oocyte maturation |
umr04919 | Thyroid hormone signaling pathway |
umr04928 | Parathyroid hormone synthesis, secretion and action |
umr04935 | Growth hormone synthesis, secretion and action |
umr05022 | Pathways of neurodegeneration - multiple diseases |
umr05163 | Human cytomegalovirus infection |
umr05166 | Human T-cell leukemia virus 1 infection |
umr05167 | Kaposi sarcoma-associated herpesvirus infection |
umr05170 | Human immunodeficiency virus 1 infection |
umr05207 | Chemical carcinogenesis - receptor activation |
umr05208 | Chemical carcinogenesis - reactive oxygen species |
umr05230 | Central carbon metabolism in cancer |
umr05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Brite |
KEGG Orthology (KO) [BR:umr00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
103679064 (MAP2K1)
04012 ErbB signaling pathway
103679064 (MAP2K1)
04014 Ras signaling pathway
103679064 (MAP2K1)
04015 Rap1 signaling pathway
103679064 (MAP2K1)
04370 VEGF signaling pathway
103679064 (MAP2K1)
04371 Apelin signaling pathway
103679064 (MAP2K1)
04668 TNF signaling pathway
103679064 (MAP2K1)
04066 HIF-1 signaling pathway
103679064 (MAP2K1)
04068 FoxO signaling pathway
103679064 (MAP2K1)
04072 Phospholipase D signaling pathway
103679064 (MAP2K1)
04071 Sphingolipid signaling pathway
103679064 (MAP2K1)
04024 cAMP signaling pathway
103679064 (MAP2K1)
04022 cGMP-PKG signaling pathway
103679064 (MAP2K1)
04151 PI3K-Akt signaling pathway
103679064 (MAP2K1)
04150 mTOR signaling pathway
103679064 (MAP2K1)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
103679064 (MAP2K1)
04148 Efferocytosis
103679064 (MAP2K1)
09143 Cell growth and death
04114 Oocyte meiosis
103679064 (MAP2K1)
04210 Apoptosis
103679064 (MAP2K1)
04218 Cellular senescence
103679064 (MAP2K1)
09144 Cellular community - eukaryotes
04510 Focal adhesion
103679064 (MAP2K1)
04540 Gap junction
103679064 (MAP2K1)
04550 Signaling pathways regulating pluripotency of stem cells
103679064 (MAP2K1)
09142 Cell motility
04810 Regulation of actin cytoskeleton
103679064 (MAP2K1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
103679064 (MAP2K1)
04620 Toll-like receptor signaling pathway
103679064 (MAP2K1)
04650 Natural killer cell mediated cytotoxicity
103679064 (MAP2K1)
04660 T cell receptor signaling pathway
103679064 (MAP2K1)
04662 B cell receptor signaling pathway
103679064 (MAP2K1)
04664 Fc epsilon RI signaling pathway
103679064 (MAP2K1)
04666 Fc gamma R-mediated phagocytosis
103679064 (MAP2K1)
04062 Chemokine signaling pathway
103679064 (MAP2K1)
09152 Endocrine system
04910 Insulin signaling pathway
103679064 (MAP2K1)
04929 GnRH secretion
103679064 (MAP2K1)
04912 GnRH signaling pathway
103679064 (MAP2K1)
04915 Estrogen signaling pathway
103679064 (MAP2K1)
04914 Progesterone-mediated oocyte maturation
103679064 (MAP2K1)
04917 Prolactin signaling pathway
103679064 (MAP2K1)
04921 Oxytocin signaling pathway
103679064 (MAP2K1)
04926 Relaxin signaling pathway
103679064 (MAP2K1)
04935 Growth hormone synthesis, secretion and action
103679064 (MAP2K1)
04919 Thyroid hormone signaling pathway
103679064 (MAP2K1)
04928 Parathyroid hormone synthesis, secretion and action
103679064 (MAP2K1)
04916 Melanogenesis
103679064 (MAP2K1)
09153 Circulatory system
04270 Vascular smooth muscle contraction
103679064 (MAP2K1)
09156 Nervous system
04725 Cholinergic synapse
103679064 (MAP2K1)
04726 Serotonergic synapse
103679064 (MAP2K1)
04720 Long-term potentiation
103679064 (MAP2K1)
04730 Long-term depression
103679064 (MAP2K1)
04722 Neurotrophin signaling pathway
103679064 (MAP2K1)
09158 Development and regeneration
04380 Osteoclast differentiation
103679064 (MAP2K1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
103679064 (MAP2K1)
05206 MicroRNAs in cancer
103679064 (MAP2K1)
05205 Proteoglycans in cancer
103679064 (MAP2K1)
05207 Chemical carcinogenesis - receptor activation
103679064 (MAP2K1)
05208 Chemical carcinogenesis - reactive oxygen species
103679064 (MAP2K1)
05230 Central carbon metabolism in cancer
103679064 (MAP2K1)
05231 Choline metabolism in cancer
103679064 (MAP2K1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
103679064 (MAP2K1)
09162 Cancer: specific types
05210 Colorectal cancer
103679064 (MAP2K1)
05212 Pancreatic cancer
103679064 (MAP2K1)
05225 Hepatocellular carcinoma
103679064 (MAP2K1)
05226 Gastric cancer
103679064 (MAP2K1)
05214 Glioma
103679064 (MAP2K1)
05216 Thyroid cancer
103679064 (MAP2K1)
05221 Acute myeloid leukemia
103679064 (MAP2K1)
05220 Chronic myeloid leukemia
103679064 (MAP2K1)
05218 Melanoma
103679064 (MAP2K1)
05211 Renal cell carcinoma
103679064 (MAP2K1)
05219 Bladder cancer
103679064 (MAP2K1)
05215 Prostate cancer
103679064 (MAP2K1)
05213 Endometrial cancer
103679064 (MAP2K1)
05224 Breast cancer
103679064 (MAP2K1)
05223 Non-small cell lung cancer
103679064 (MAP2K1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
103679064 (MAP2K1)
05170 Human immunodeficiency virus 1 infection
103679064 (MAP2K1)
05161 Hepatitis B
103679064 (MAP2K1)
05160 Hepatitis C
103679064 (MAP2K1)
05164 Influenza A
103679064 (MAP2K1)
05163 Human cytomegalovirus infection
103679064 (MAP2K1)
05167 Kaposi sarcoma-associated herpesvirus infection
103679064 (MAP2K1)
05165 Human papillomavirus infection
103679064 (MAP2K1)
09171 Infectious disease: bacterial
05132 Salmonella infection
103679064 (MAP2K1)
05135 Yersinia infection
103679064 (MAP2K1)
09164 Neurodegenerative disease
05010 Alzheimer disease
103679064 (MAP2K1)
05022 Pathways of neurodegeneration - multiple diseases
103679064 (MAP2K1)
09165 Substance dependence
05034 Alcoholism
103679064 (MAP2K1)
09167 Endocrine and metabolic disease
04934 Cushing syndrome
103679064 (MAP2K1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
103679064 (MAP2K1)
01522 Endocrine resistance
103679064 (MAP2K1)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:umr01001]
103679064 (MAP2K1)
Enzymes [BR:umr01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.12 Dual-specificity kinases (those acting on Ser/Thr and Tyr residues)
2.7.12.2 mitogen-activated protein kinase kinase
103679064 (MAP2K1)
Protein kinases [BR:umr01001]
Serine/threonine kinases: STE group
STE7 family
103679064 (MAP2K1)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
Unknown
|
AA seq |
393 aa
MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQKQKV
GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE
CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL
REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY
SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY
GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF
IKRSDGEEVDFAGWLCSTIGLNQPSTPTHAAGV |
NT seq |
1182 nt +upstreamnt +downstreamnt
atgcccaagaagaagccgacgcccatccagctgaacccggcccccgacggctccgcggtt
aacgggaccagctcggcggagaccaacctggaggccttgcagaagaagctggaggagctg
gagctcgatgagcagcagcggaagcgcctggaggccttcctcacccagaagcagaaggtc
ggggaattgaaggatgacgactttgagaagatcagtgagctgggcgctggcaacggtggt
gtggtgttcaaggtctcccacaagccctccggcctggtcatggccagaaagctaattcac
ctggagatcaaacctgcaatccggaatcagatcataagagagctgcaggttctgcacgag
tgcaactcgccttacattgtgggcttctatggtgcgttctacagcgatggcgagatcagt
atctgcatggaacatatggatgggggttccttggatcaagtcctgaagaaagctggaaga
attcctgaacaaattttaggaaaagttagcattgctgtaataaaaggtctgacttacctg
agggagaagcacaagattatgcacagagatgtcaagccttccaacatcctcgtgaactcc
cgtggggagatcaagctctgtgactttggggtcagtgggcagctcatcgactccatggcc
aactccttcgtgggcacaaggtcctacatgtcgccagaaagactccaggggactcattac
tcggtgcagtcggacatctggagcatggggctctctctggttgagatggcggtggggagg
tatcccatccctcctccagatgccaaggagctggagctgatgtttgggtgccaagtggag
ggagatgcggctgagacgccacccagaccaaggacccccggaaggcccctcagctcttac
ggaatggacagccggcctcccatggcgatttttgagttgctggattacatagtcaacgag
cctcctccaaaactgcccagtggagttttcagtctggaatttcaagattttgtgaataaa
tgcttaataaaaaaccccgcagagagagcagatctgaagcaactcatggttcatgccttc
atcaagagatcggacggggaagaagtggattttgcaggttggctctgctccaccatcggc
cttaaccagcccagcacaccgacccacgcagccggcgtctaa |